{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T04:51:20Z","timestamp":1770267080083,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.neuropharm.2008.05.002","type":"journal-article","created":{"date-parts":[[2008,5,10]],"date-time":"2008-05-10T09:07:20Z","timestamp":1210410440000},"page":"148-153","source":"Crossref","is-referenced-by-count":25,"title":["Imidazenil: A low efficacy agonist at \u03b11- but high efficacy at \u03b15-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem"],"prefix":"10.1016","volume":"55","author":[{"given":"James","family":"Auta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Impagnatiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashkim","family":"Kadriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erminio","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.05.002_bib1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1471-4159.2001.00664.x","article-title":"Chronic benzodiazepine treatment of cells expressing recombinant GABAA receptors uncouples allosteric binding: studies on possible mechanisms","volume":"79","author":"Ali","year":"2001","journal-title":"Journal of Neurochemistry"},{"issue":"6","key":"10.1016\/j.neuropharm.2008.05.002_bib2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib3","first-page":"1262","article-title":"Imidazenil, a positive allosteric modulator of GABAA receptors exhibits low tolerance and dependence liabilities","volume":"270","author":"Auta","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/j.neuropharm.2008.05.002_bib4","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1073\/pnas.97.5.2314","article-title":"Imidazenil prevention of alprazolam-induced acquisition deficit in Patas monkeys is devoid of tolerance","volume":"97","author":"Auta","year":"2000","journal-title":"Proceeding of the National Academy of Science USA"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","author":"Bateson","year":"2002","journal-title":"Current Pharmaceutical Design"},{"issue":"2","key":"10.1016\/j.neuropharm.2008.05.002_bib6","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1471-4159.1997.69020806.x","article-title":"GABAA receptors containing the \u03b14-subunit: prevalence, distribution, pharmacology, and subunit architecture in situ","volume":"69","author":"Benke","year":"1997","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.neuropharm.2008.05.002_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1523\/JNEUROSCI.16-01-00283.1996","article-title":"Laminar compartmentalization of GABAA receptor subtypes in the spinal cord: an immunohistochemical study","volume":"16","author":"Bohlhalter","year":"1996","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib8","first-page":"2227","article-title":"Identification of a novel, selective GABAA alpha5 receptor inverse agonist which enhances cognition","volume":"46","author":"Chambers","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0165-6147(96)10015-8","article-title":"Benzodiazepines on trial: a research strategy for their rehabilitation","volume":"17","author":"Costa","year":"1996","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib10","first-page":"227","article-title":"Tolerance and dependence to ligands of benzodiazepine recognition sites expressed by GABAA receptors","volume":"vol. 50","author":"Costa","year":"2001"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0028-3908(02)00199-5","article-title":"GABAA receptors and benzodiazepines: a role for dendritic resident mRNAs","volume":"43","author":"Costa","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1615\/CritRevNeurobiol.v15.i2.20","article-title":"GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability","volume":"15","author":"Costa","year":"2003","journal-title":"Critical Reviews in Neurobiology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.bjp.0703717","article-title":"Mechanism of action of the hypnotic zolpidem in vivo","volume":"131","author":"Crestani","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/mol.59.3.442","article-title":"Molecular targets for the myorelaxant action of diazepam","volume":"59","author":"Crestani","year":"2001","journal-title":"Molecular Pharmacology"},{"issue":"13","key":"10.1016\/j.neuropharm.2008.05.002_bib16","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal \u03b15 GABAA receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proceeding of the National Academy of Science USA"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/308074a0","article-title":"Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity","volume":"308","author":"Gallager","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(94)90470-7","article-title":"Chronic administration of an anticonvulsant dose of imidazenil fails to induce tolerance of GABAA receptor function in mice","volume":"254","author":"Ghiani","year":"1994","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib19","first-page":"1018","article-title":"Imidazenil: a new partial positive allosteric modulator of GABA action at GABAA receptors","volume":"266","author":"Giusti","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib20","first-page":"191","article-title":"Absolute quantitation of \u03b3-aminobutyric acid a receptor subunit messenger RNAs by competitive polymerase chain reaction","volume":"12","author":"Grayson","year":"1993","journal-title":"Methods in Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","article-title":"GABAergic dysfunction in schizophrenia: a new treatment target on the horizon","volume":"180","author":"Guidotti","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02876917","article-title":"Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain","volume":"2","author":"Heninger","year":"1990","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib23","first-page":"822","article-title":"Modifications of \u03b3-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam","volume":"49","author":"Impagnatiello","year":"1996","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes","volume":"451","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib25","first-page":"1253","article-title":"Pharmacological modulation of diazepam-insensitive recombinant \u03b3-aminobutyric acidA receptors \u03b12\u03b22\u03b32 and \u03b16\u03b22\u03b32","volume":"50","author":"Knoflach","year":"1996","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1124\/jpet.102.036665","article-title":"Molecular and pharmacological characterization of GABAA receptor \u03b11 subunit knockout mice","volume":"302","author":"Kralic","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"Pt.3","key":"10.1016\/j.neuropharm.2008.05.002_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1113\/jphysiol.2006.122135","article-title":"Enhanced macroscopic desensitization shapes the response of \u03b14 subtype-containing GABAA receptors to synaptic and extra synaptic GABA","volume":"578","author":"Lagrange","year":"2007","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib28","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0028-3908(96)00071-8","article-title":"Reversible modification of GABAA receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction","volume":"35","author":"Longone","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neural substrate for the selective attenuation of anxiety","volume":"290","author":"Low","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-2999(89)90151-9","article-title":"Chronic diazepam treatment produces regional specific changes in GABA-stimulated chloride influx","volume":"159","author":"Marley","year":"1989","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype","volume":"3","author":"Mckernan","year":"2000","journal-title":"Nature Neuroscience"},{"issue":"5","key":"10.1016\/j.neuropharm.2008.05.002_bib32","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1073\/pnas.84.5.1444","article-title":"Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine\/\u03b2 carboline recognition site","volume":"84","author":"Miyata","year":"1987","journal-title":"Proceeding of the National Academy of Science USA"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1471-4892(01)00008-X","article-title":"GABAA-receptor subtypes: a new pharmacology","volume":"1","author":"Mohler","year":"2001","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib34","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0278-5846(02)00305-6","article-title":"Anxiogenic-like activity of L-655,708, a selective ligand for the benzodiazepine site of GABAA receptors which contain the alpha-5 subunit, in the elevated plus-maze test","volume":"26","author":"Navarro","year":"2002","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ab.20032","article-title":"Behavioral profile of L-655,708, a selective ligand for the benzodiazepine site of GABAA receptors which contain the alpha-5 subunit, in social encounters between male mice","volume":"30","author":"Navarro","year":"2004","journal-title":"Aggressive Behavior"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0165-6147(86)90420-7","article-title":"Benzodiazepine dependence in the clinic: a cause for anxiety?","volume":"7","author":"Nutt","year":"1986","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2","key":"10.1016\/j.neuropharm.2008.05.002_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0306-4522(96)00609-4","article-title":"Tolerance to diazepam and changes in GABAA receptor subunit expression in rat neocortical areas","volume":"79","author":"Pesold","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0922-4106(92)90078-A","article-title":"GABA receptor subunit mRNA levels are differentially influenced by chronic FG 7142 and diazepam exposure","volume":"226","author":"Primus","year":"1992","journal-title":"European Journal of Pharmacology"},{"issue":"9-10","key":"10.1016\/j.neuropharm.2008.05.002_bib39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0028-3908(96)00061-5","article-title":"[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit","volume":"35","author":"Quirk","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.pharmtox.44.101802.121429","article-title":"Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepine and general anesthetics through mouse genetics","volume":"44","author":"Rudolph","year":"2004","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine action mediated by specific gamma-aminobutyric acid (A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib42","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1523\/JNEUROSCI.21-10-03409.2001","article-title":"Loss of the major GABAA receptor subtype in the brain is not lethal in mice","volume":"21","author":"Sur","year":"2001","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib43","first-page":"761","article-title":"U-90042, a sedative\/hypnotic compound that interacts differentially with GABAA receptor subtypes","volume":"275","author":"Tang","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib44","first-page":"284","article-title":"Autoradiographic localization of benzodiazepine receptor downregulation","volume":"236","author":"Tietz","year":"1986","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"30","key":"10.1016\/j.neuropharm.2008.05.002_bib45","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1523\/JNEUROSCI.1067-04.2004","article-title":"Requirement of \u03b15-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice","volume":"24","author":"van Rijnsoever","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coph.2004.08.006","article-title":"GABAA receptor subtypes: any clue to benzodiazepine dependence?","volume":"5","author":"Wafford","year":"2005","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib47","first-page":"151","article-title":"Benzodiazepines: use, abuse, and consequences","volume":"44","author":"Woods","year":"1992","journal-title":"Pharmacology Review"},{"key":"10.1016\/j.neuropharm.2008.05.002_bib48","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1111\/j.1460-9568.2004.03642.x","article-title":"GABAA receptors containing the \u03b15 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear","volume":"20","author":"Yee","year":"2004","journal-title":"European Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.neuropharm.2008.05.002_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1476-5381.1996.tb15239.x","article-title":"Lack of anticonvulsant tolerance and benzodiazepine receptor down-regulation with imidazenil in rats","volume":"117","author":"Zanotti","year":"1996","journal-title":"British Journal of Pharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T07:29:56Z","timestamp":1557559796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0028390808001299"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.05.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}